ORIC Pharmaceuticals Inc (ORIC) stock has fallen -76.03% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives ORIC stock a score of 33 out of a possible 100.
That rank is mainly influenced by a long-term technical score of 1. ORIC's rank also includes a short-term technical score of 4. The fundamental score for ORIC is 94. In addition to the average rating from Wall Street analysts, ORIC stock has a mean target price of $19.00. This means analysts expect the stock to rise 302.54% over the next 12 months. ORIC has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on ORIC!